Share:
DENVER, Feb. 10, 2021 (GLOBE NEWSWIRE) Bonanza Creek Energy, Inc. (NYSE:BCEI) (the Company or Bonanza Creek ) today announced that a special meeting of stockholders of the Company (the Bonanza Creek special meeting ) is scheduled to take place on March 12, 2021 at 9:00 a.m., Mountain Time. The purpose of the Bonanza Creek special meeting is to approve the issuance of Bonanza Creek common stock to stockholders and noteholders of HighPoint Resources Corporation ( HighPoint ) in connection with the transaction pursuant to the Agreement and Plan of Merger, dated as of November 9, 2020, by and among the Company, HighPoint and Boron Merger Sub, Inc. (as amended from time to time, the merger agreement ). The record date for Bonanza Creek stockholders entitled to vote at the Bonanza Creek special meeting is the close of business on February 1, 2021.
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
News provided by
Share this article
Share this article
ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 /PRNewswire/ Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ( Company, CBMG, we or our ), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that leading proxy advisory firms Glass, Lewis & Co. and Institutional Shareholder Services Inc. have both recommended that the Company s stockholders vote
FOR the proposal to adopt the definitive merger agreement that provides for the acquisition of CBMG for $19.75 in cash per share of common stock in a going private transaction (the merger proposal ).
Home / Top News / Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares
Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares
Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the proposed aggregate number of shares of common stock that the Company would be authorized to issue from 500,000,000 shares to 400,000,000 shares
MALVERN, Pa., Dec. 22, 2020 (GLOBE NEWSWIRE)
Ocugen, Inc
. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that it will convene its 2020 Annual Meeting of Stockholders on December 23, 2020 at 11:00 a.m. Eastern time and, after conducting all other business, intends to adjourn the meeting solely with respect to Item 2 set forth in
Ocugen Inc Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.